Survival following treatment of a cardiac malignant fibrous histiocytoma.
The authors report the successful surgical and chemotherapeutic management of a malignant fibrous histiocytoma with localization in the heart. This rare malignancy has specific morphologic characteristics and is diagnosed in adults when it is already locally aggressive or metastasized. The average survival time for patients with malignant fibrous histiocytoma is < 12 months. Neither clinical nor instrumental signs of recurrence have been detected in this patient after an aggressive surgical resection and a specific therapeutic approach.
Schena
S
S
Institute of Cardiac Surgery, Institute of Pathology, Medical School, University of Bari, Italy. sschena@med.miami.edu
Caniglia
A
A
Agnino
A
A
Caruso
G
G
Ferlan
G
G
D000368:Aged; D017024:Chemotherapy, Adjuvant; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D006801:Humans